Impact of switching from cigarette smoking to tobacco heating system use on biomarkers of potential harm in a randomized trial

References

• Akiyama Y, Sherwood N. 2021. Systematic review of biomarker findings from clinical studies of electronic cigarettes and heated tobacco products. Toxicol Rep. 8:282–294. doi:10.1016/j.toxrep.2021.01.014
   PubMed Web of Science ®Google Scholar
• Andelid K, Bake B, Rak S, Lindén A, Rosengren A, Ekberg-Jansson A. 2007. Myeloperoxidase as a marker of increasing systemic inflammation in smokers without severe airway symptoms. Respir Med. 101(5):888–895. doi:10.1016/j.rmed.2006.09.023
   PubMed Web of Science ®Google Scholar
• Ashley DL, De Jesús VR, Abulseoud OA, Huestis MA, Milan DF, Blount BC. 2020. Urinary acrylonitrile metabolite concentrations before and after smoked, vaporized, and oral cannabis in frequent and occasional cannabis users. Int J Environ Res Public Health. 17(18):6438. doi:10.3390/ijerph17186438
   PubMed Web of Science ®Google Scholar
• Bake B, Oxhöj H, Sixt R, Wilhelmsen L. 1977. Ventilatory lung function following two years of tobacco abstinence. Scand J Respir Dis. 58(6):311–318.
   PubMedGoogle Scholar
• Beaglehole R, Bates C, Youdan B, Bonita R. 2019. Nicotine without smoke: fighting the tobacco epidemic with harm reduction. Lancet. 394(10200):718–720. doi:10.1016/S0140-6736(19)31884-7
   PubMed Web of Science ®Google Scholar
• Bekki K, Inaba Y, Uchiyama S, Kunugita N. 2017. Comparison of chemicals in mainstream smoke in heat-not-burn tobacco and combustion cigarettes. J Uoeh. 39(3):201–207. doi:10.7888/juoeh.39.201
   PubMedGoogle Scholar
• Bjartveit K, Tverdal A. 2005. Health consequences of smoking 1-4 cigarettes per day. Tob Control. 14(5):315–320. doi:10.1136/tc.2005.011932
   PubMed Web of Science ®Google Scholar
• Brischetto CS, Connor WE, Connor SL, Matarazzo JD. 1983. Plasma lipid and lipoprotein profiles of cigarette smokers from randomly selected families: enhancement of hyperlipidemia and depression of high-density lipoprotein. Am J Cardiol. 52(7):675–680. doi:10.1016/0002-9149(83)90396-x
   PubMed Web of Science ®Google Scholar
• Buist AS, Sexton GJ, Nagy JM, Ross BB. 1976. The effect of smoking cessation and modification on lung function. Am Rev Respir Dis. 114(1):115–122. doi:10.1164/arrd.1976.114.1.115
   PubMedGoogle Scholar
• Butkiewicz AM, Kemona-Chetnik I, Dymicka-Piekarska V, Matowicka-Karna J, Kemona H, Radziwon P. 2006. Does smoking affect thrombocytopoiesis and platelet activation in women and men? Adv Med Sci. 51:123–126.
   PubMedGoogle Scholar
• Caponnetto P, Maglia M, Prosperini G, Busà B, Polosa R. 2018. Carbon monoxide levels after inhalation from new generation heated tobacco products. Respir Res. 19(1):164. doi:10.1186/s12931-018-0867-z
   PubMedGoogle Scholar
• Caponnetto P, Russo C, Di Maria A, Morjaria JB, Barton S, Guarino F, Basile E, Proiti M, Bertino G, Cacciola RR, et al. 2011. Circulating endothelial-coagulative activation markers after smoking cessation: a 12-month observational study. Eur J Clin Invest. 41(6):616–626. doi:10.1111/j.1365-2362.2010.02449.x
   PubMed Web of Science ®Google Scholar
• Carmella SG, Chen M, Han S, Briggs A, Jensen J, Hatsukami DK, Hecht SS. 2009. Effects of smoking cessation on eight urinary tobacco carcinogen and toxicant biomarkers. Chem Res Toxicol. 2012 Mar 1925(3):763–763. doi:10.1021/tx300048h
   Google Scholar
• Centers for Disease Control and Prevention. 2020a. Electronic cigarettes. Centers for Disease Control and Prevention. https://www.cdc.gov/tobacco/basic_information/e-cigarettes/index.htm. [Accessed September 10, 2020].
   Google Scholar
• Centers for Disease Control and Prevention. 2020b. Smoking cessation: fast facts. Centers for Disease Control and Prevention. https://www.cdc.gov/tobacco/data_statistics/fact_sheets/cessation/smoking-cessation-fast-facts/index.html
   Google Scholar
• Chang CM, Cheng YC, Cho TM, Mishina EV, Del Valle-Pinero AY, van Bemmel DM, Hatsukami DK. 2019. Biomarkers of potential harm: summary of an FDA-sponsored public workshop. Nicotine Tob Res. 21(1):3–13. doi:10.1093/ntr/ntx273
   PubMed Web of Science ®Google Scholar
• Chehne F, Oguogho A, Lupattelli G, Palumbo B, Sinzinger H. 2002. Effect of giving up cigarette smoking and restarting in patients with clinically manifested atherosclerosis. Prostaglandins Leukot Essent Fatty Acids. 67(5):333–339. doi:10.1054/plef.2002.0438
   PubMed Web of Science ®Google Scholar
• Chen L-F, Li S-C, Yang C-D, Zhang Y, Feng C, Wu W-L, Yan X-W. 2018. Cigarette smoking-induced low-density lipoprotein (LDL) dysfunction is partially reversible after smoking cessation. Int J Clin Exp Med. 11(11):11732.
   Web of Science ®Google Scholar
• Clarke E, Thompson K, Weaver S, Thompson J, O’Connell G. 2019. Snus: a compelling harm reduction alternative to cigarettes. Harm Reduct J. 16(1):62. doi:10.1186/s12954-019-0335-1
   PubMed Web of Science ®Google Scholar
• Conklin DJ, Schick S, Blaha MJ, Carll A, DeFilippis A, Ganz P, Hall ME, Hamburg N, O’Toole T, Reynolds L, et al. 2019. Cardiovascular injury induced by tobacco products: assessment of risk factors and biomarkers of harm. A Tobacco Centers of Regulatory Science compilation. Am J Physiol Heart Circ Physiol. 316(4):H801–h827. doi:10.1152/ajpheart.00591.2018
   PubMed Web of Science ®Google Scholar
• Connor Gorber S, Schofield-Hurwitz S, Hardt J, Levasseur G, Tremblay M. 2009. The accuracy of self-reported smoking: a systematic review of the relationship between self-reported and cotinine-assessed smoking status. Nicotine Tob Res. 11(1):12–24. doi:10.1093/ntr/ntn010
   PubMed Web of Science ®Google Scholar
• DiClemente CC, Prochaska JO, Fairhurst S, Velicer WF, Rossi JS, Velasquez M. 1991. The process of smoking cessation: an analysis of precontemplation, contemplation, and preparation stages of change. J Consult Clin Psychol. 59(2):295–304. doi:10.1037/0022-006x.59.2.295
   PubMed Web of Science ®Google Scholar
• Drovandi A, Salem S, Barker D, Booth D, Kairuz T. 2019. Human biomarker exposure from cigarettes versus novel heat-not-burn devices: a systematic review and meta-analysis. Nicotine Tob Res. 22(7):1077–1085. doi:10.1093/ntr/ntz200
   Web of Science ®Google Scholar
• El-Deek SE, Makhlouf HA, Saleem TH, Mandour MA, Mohamed NA. 2013. Surfactant protein D, soluble intercellular adhesion molecule-1 and high-sensitivity C-reactive protein as biomarkers of chronic obstructive pulmonary disease. Med Princ Pract. 22(5):469–474. doi:10.1159/000349934
   PubMed Web of Science ®Google Scholar
• Emma R, Caponnetto P, Cibella F, Caruso M, Conte G, Benfatto F, Ferlito S, Gulino A, Polosa R. 2020. Short and long term repeatability of saccharin transit time in current, former, and never smokers. Front Physiol. 11:1109. doi:10.3389/fphys.2020.01109
   PubMed Web of Science ®Google Scholar
• Ergüder IB, Ergüder T, Ozkan C, Bozkurt N, Soylu K, Devrim E, Durak I. 2006. Short-term effects of smoking cessation on blood antioxidant parameters and paraoxonase activity in healthy asymptomatic long-term cigarette smokers. Inhal Toxicol. 18(8):575–579. doi:10.1080/08958370600686325
   PubMed Web of Science ®Google Scholar
• Farsalinos KE, Yannovits N, Sarri T, Voudris V, Poulas K, Leischow S. 2018. Carbonyl emissions from a novel heated tobacco product (IQOS): comparison with an e-cigarette and a tobacco cigarette. Addiction. 113(11):2099–2106. doi:10.1111/add.14365
   PubMed Web of Science ®Google Scholar
• [FDA] Food and Drug Administration. 2018. Guidance for industry - Bioanalytical method validation.
   Google Scholar
• [FDA] Food and Drug Administration. 2020. FDA News Release, July 7 2020: FDA Authorizes Marketing of IQOS Tobacco Heating System with ‘Reduced Exposure’ Information.
   Google Scholar
• Forey BA, Fry JS, Lee PN, Thornton AJ, Coombs KJ. 2013. The effect of quitting smoking on HDL-cholesterol - A review based on within-subject changes. Biomark Res. 1(1):26. doi:10.1186/2050-7771-1-26
   PubMedGoogle Scholar
• Forster M, Fiebelkorn S, Yurteri C, Mariner D, Liu C, Wright C, McAdam K, Murphy J, Proctor C. 2017. Assessment of novel tobacco heating product THP1.0. Part 3: comprehensive chemical characterisation of harmful and potentially harmful aerosol emissions. Regul Toxicol Pharmacol. 93:14–33. doi:10.1016/j.yrtph.2017.10.006
   PubMed Web of Science ®Google Scholar
• Franck C, Filion KB, Kimmelman J, Grad R, Eisenberg MJ. 2016. Ethical considerations of e-cigarette use for tobacco harm reduction. Respir Res. 17(1):53. doi:10.1186/s12931-016-0370-3
   PubMedGoogle Scholar
• Gale N, McEwan M, Camacho OM, Hardie G, Proctor CJ, Murphy J. 2021. Changes in biomarkers after 180 days of tobacco heating product use: a randomised trial. Intern Emerg Med. 16(8):2201–2212. doi:10.1007/s11739-021-02798-6
   PubMed Web of Science ®Google Scholar
• Gale N, McEwan M, Hardie G, Proctor CJ, Murphy J. 2022. Changes in biomarkers of exposure and biomarkers of potential harm after 360 days in smokers who either continue to smoke, switch to a tobacco heating product or quit smoking. Intern Emerg Med. 17(7):2017–2030. doi:10.1007/s11739-022-03062-1
   PubMed Web of Science ®Google Scholar
• [GOLD] Global Initiative for Chronic Obstructive Lung Disease. 2020. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2020. https://goldcopd.org/gold-reports/
   Google Scholar
• [GOLD] Global Initiative for Chronic Obstructive Lung Disease. 2013. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary diseases. Updated 2013.
   Google Scholar
• Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, Jacobs DR, Bangdiwala S, Tyroler HA. 1989. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 79(1):8–15. doi:10.1161/01.cir.79.1.8
   PubMed Web of Science ®Google Scholar
• Goujon C, Kleinhans S, Maeder S, Poget L, Schaller J. 2020. Robustness of HPHC reduction for THS 2.2 aerosol compared with 3R4F reference cigarette smoke under high intensity puffing conditions. Beiträge Zur Tabakforschung International. 29(2):66–83. doi:10.2478/cttr-2020-0008
   Google Scholar
• Hackshaw A, Morris JK, Boniface S, Tang J-L, Milenković D. 2018. Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports. BMJ. 360:j5855. doi:10.1136/bmj.j5855
   PubMed Web of Science ®Google Scholar
• Hammett CJ, Prapavessis H, Baldi JC, Ameratunga R, Schoenbeck U, Varo N, French JK, White HD, Stewart RA. 2007. Variation in blood levels of inflammatory markers related and unrelated to smoking cessation in women. Prev Cardiol. 10(2):68–75. doi:10.1111/j.1520-037x.2007.05957.x
   PubMedGoogle Scholar
• Hankinson JL, Odencrantz JR, Fedan KB. 1999. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 159(1):179–187. doi:10.1164/ajrccm.159.1.9712108
   PubMed Web of Science ®Google Scholar
• Hatsukami DK, Carroll DM. 2020. Tobacco harm reduction: past history, current controversies and a proposed approach for the future. Prev Med. 140:106099. doi:10.1016/j.ypmed.2020.106099
   PubMed Web of Science ®Google Scholar
• Haustein KO, Krause J, Haustein H, Rasmussen T, Cort N. 2002. Effects of cigarette smoking or nicotine replacement on cardiovascular risk factors and parameters of haemorheology. J Intern Med. 252(2):130–139. doi:10.1046/j.1365-2796.2002.01014.x
   PubMed Web of Science ®Google Scholar
• Haziza C, de La Bourdonnaye G, Skiada D, Ancerewicz J, Baker G, Picavet P, Lüdicke F. 2016. Evaluation of the Tobacco Heating System 2.2. Part 8: 5-day randomized reduced exposure clinical study in Poland. Regul Toxicol Pharmacol. 81(Suppl 2):S139–S150. doi:10.1016/j.yrtph.2016.11.003
   PubMed Web of Science ®Google Scholar
• Haziza C, de La Bourdonnaye G, Skiada D, Ancerewicz J, Baker G, Picavet P, Lüdicke F. 2017. Biomarker of exposure level data set in smokers switching from conventional cigarettes to Tobacco Heating System 2.2, continuing smoking or abstaining from smoking for 5 days. Data Brief. 10:283–293. doi:10.1016/j.dib.2016.11.047
   PubMedGoogle Scholar
• Hecht SS, Stepanov I, Carmella SG. 2016. Exposure and metabolic activation biomarkers of carcinogenic tobacco-specific nitrosamines. Acc Chem Res. 49(1):106–114. doi:10.1021/acs.accounts.5b00472
   PubMed Web of Science ®Google Scholar
• [IOM] Institute of Medicine. 2001. Clearing the smoke - Assessing the science base for tobacco harm reduction. Washington, DC: The National Academies Press. http://www.nap.edu/catalog/10029.html
   Google Scholar
• Jakubowski M, Linhart I, Pielas G, Kopecký J. 1987. 2-Cyanoethylmercapturic acid (CEMA) in the urine as a possible indicator of exposure to acrylonitrile. Br J Ind Med. 44(12):834–840. doi:10.1136/oem.44.12.834
   PubMedGoogle Scholar
• Jensen EJ, Pedersen B, Frederiksen R, Dahl R. 1998. Prospective study on the effect of smoking and nicotine substitution on leucocyte blood counts and relation between blood leucocytes and lung function. Thorax. 53(9):784–789. doi:10.1136/thx.53.9.784
   PubMed Web of Science ®Google Scholar
• Kambam JR, Chen LH, Hyman SA. 1986. Effect of short-term smoking halt on carboxyhemoglobin levels and P50 values. Anesth Analg. 65(11):1186–1188.
   PubMed Web of Science ®Google Scholar
• Lee KK, Matos S, Evans DH, White P, Pavord ID, Birring SS. 2013. A longitudinal assessment of acute cough. Am J Respir Crit Care Med. 187(9):991–997. doi:10.1164/rccm.201209-1686OC
   PubMed Web of Science ®Google Scholar
• Lee PN, Forey BA, Fry JS, Thornton AJ, Coombs KJ. 2014. The effect of quitting smoking on white blood cell count - A review based on within-subject changes. http://www.pnlee.co.uk/documents/refs/lee2014D.pdf
   Google Scholar
• Lee PN, Fry JS. 2010. Systematic review of the evidence relating FEV1 decline to giving up smoking. BMC Med. 8(1):84. doi:10.1186/1741-7015-8-84
   PubMedGoogle Scholar
• Levy DT, Chaloupka F, Gitchell J. 2004. The effects of tobacco control policies on smoking rates: a tobacco control scorecard. J Public Health Manag Pract. 10(4):338–353. doi:10.1097/00124784-200407000-00011
   PubMedGoogle Scholar
• Li X, Luo Y, Jiang X, Zhang H, Zhu F, Hu S, Hou H, Hu Q, Pang Y. 2019. Chemical analysis and simulated pyrolysis of Tobacco Heating System 2.2 compared to conventional cigarettes. Nicotine Tob Res. 21(1):111–118. doi:10.1093/ntr/nty005
   PubMed Web of Science ®Google Scholar
• Lüdicke F, Ansari SM, Lama N, Blanc N, Bosilkovska M, Donelli A, Picavet P, Baker G, Haziza C, Peitsch M, et al. 2019. Effects of switching to a heat-not-burn tobacco product on biologically relevant biomarkers to assess a candidate modified risk tobacco product: a randomized trial. Cancer Epidemiol Biomarkers Prev. 28(11):1934–1943. doi:10.1158/1055-9965.EPI-18-0915
   PubMed Web of Science ®Google Scholar
• Lüdicke F, Picavet P, Baker G, Haziza C, Poux V, Lama N, Weitkunat R. 2018a. Effects of switching to the Menthol Tobacco Heating System 2.2, smoking abstinence, or continued cigarette smoking on clinically relevant risk markers: a randomized, controlled, open-label, multicenter study in sequential confinement and ambulatory settings (Part 2). Nicotine Tob Res. 20(2):173–182. doi:10.1093/ntr/ntx028
   PubMed Web of Science ®Google Scholar
• Lüdicke F, Picavet P, Baker G, Haziza C, Poux V, Lama N, Weitkunat R. 2018b. Effects of switching to the Tobacco Heating System 2.2 menthol, smoking abstinence, or continued cigarette smoking on biomarkers of exposure: a randomized, controlled, open-label, multicenter study in sequential confinement and ambulatory settings (Part 1). Nicotine Tob Res. 20(2):161–172. doi:10.1093/ntr/ntw287
   PubMed Web of Science ®Google Scholar
• Maeda K, Noguchi Y, Fukui T. 2003. The effects of cessation from cigarette smoking on the lipid and lipoprotein profiles: a meta-analysis. Prev Med. 37(4):283–290. doi:10.1016/s0091-7435(03)00110-5
   PubMed Web of Science ®Google Scholar
• Mallock N, Böss L, Burk R, Danziger M, Welsch T, Hahn H, Trieu H-L, Hahn J, Pieper E, Henkler-Stephani F, et al. 2018. Levels of selected analytes in the emissions of “heat not burn” tobacco products that are relevant to assess human health risks. Arch Toxicol. 92(6):2145–2149. doi:10.1007/s00204-018-2215-y
   PubMed Web of Science ®Google Scholar
• Mallock N, Pieper E, Hutzler C, Henkler-Stephani F, Luch A. 2019. Heated tobacco products: a review of current knowledge and initial assessments. Front Public Health. 7:287. doi:10.3389/fpubh.2019.00287
   PubMed Web of Science ®Google Scholar
• McNeill A, Simonavičius E, Brose L, Taylor E, East K, Zuikova E, Calder R, Robson D. 2022. Nicotine vaping in England: an evidence update including health risks and perceptions, 2022.
   Google Scholar
• Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, et al. 2005. Standardisation of spirometry. Eur Respir J. 26(2):319–338. doi:10.1183/09031936.05.00034805
   PubMed Web of Science ®Google Scholar
• Minet E, Cheung F, Errington G, Sterz K, Scherer G. 2011. Urinary excretion of the acrylonitrile metabolite 2-cyanoethylmercapturic acid is correlated with a variety of biomarkers of tobacco smoke exposure and consumption. Biomarkers. 16(1):89–96. doi:10.3109/1354750X.2010.533287
   PubMed Web of Science ®Google Scholar
• Morita H, Ikeda H, Haramaki N, Eguchi H, Imaizumi T. 2005. Only two-week smoking cessation improves platelet aggregability and intraplatelet redox imbalance of long-term smokers. J Am Coll Cardiol. 45(4):589–594. doi:10.1016/j.jacc.2004.10.061
   PubMed Web of Science ®Google Scholar
• Ogawa K, Tanaka T, Nagoshi T, Sekiyama H, Arase S, Minai K, Ogawa T, Yoshimura M. 2015. Increase in the oxidised low-density lipoprotein level by smoking and the possible inhibitory effect of statin therapy in patients with cardiovascular disease: a retrospective study. BMJ Open. 5(1):e005455. doi:10.1136/bmjopen-2014-005455
   PubMed Web of Science ®Google Scholar
• Palmer RM, Stapleton JA, Sutherland G, Coward PY, Wilson RF, Scott DA. 2002. Effect of nicotine replacement and quitting smoking on circulating adhesion molecule profiles (sICAM-1, sCD44v5, sCD44v6). Eur J Clin Invest. 32(11):852–857. doi:10.1046/j.1365-2362.2002.01067.x
   PubMed Web of Science ®Google Scholar
• Peck MJ, Sanders EB, Scherer G, Lüdicke F, Weitkunat R. 2018. Review of biomarkers to assess the effects of switching from cigarettes to modified risk tobacco products. Biomarkers. 23(3):213–244. doi:10.1080/1354750X.2017.1419284
   PubMed Web of Science ®Google Scholar
• Philip Morris Products S.A. 2015. Evaluation of biological and functional changes in healthy Smokers after switching to THS 2.2 for 26 weeks [ZRHR-ERS-09-US]. Bethesda (MD): National Library of Medicine (US). https://clinicaltrials.gov/ct2/show/NCT02396381
   Google Scholar
• Pilz H, Oguogho A, Chehne F, Lupattelli G, Palumbo B, Sinzinger H. 2000. Quitting cigarette smoking results in a fast improvement of in vivo oxidation injury (determined via plasma, serum and urinary isoprostane). Thromb Res. 99(3):209–221. doi:10.1016/s0049-3848(00)00249-8
   PubMed Web of Science ®Google Scholar
• Polosa R, Morjaria JB, Prosperini U, Busà B, Pennisi A, Gussoni G, Rust S, Maglia M, Caponnetto P. 2021. Health outcomes in COPD smokers using heated tobacco products: a 3-year follow-up. Intern Emerg Med. 16(3):687–696. doi:10.1007/s11739-021-02674-3
   PubMed Web of Science ®Google Scholar
• Prochaska JO, DiClemente CC. 1983. Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol. 51:3, 390–5.
   PubMed Web of Science ®Google Scholar
• Public Health England. 2016. E-cigarettes: a developing public health consensus. London, England, United Kingdom.
   Google Scholar
• Rångemark C, Ciabattoni G, Wennmalm A. 1993. Excretion of thromboxane metabolites in healthy women after cessation of smoking. Arterioscler Thromb. 13(6):777–782. doi:10.1161/01.atv.13.6.777
   PubMedGoogle Scholar
• Rodgman A, Perfetti TA. 2013. The chemical components of tobacco and tobacco smoke. 2nd ed. CRC Press, Taylor & Francis Inc (United States). Public Health England.
   Google Scholar
• Rodu B. 2011. The scientific foundation for tobacco harm reduction, 2006-2011. Harm Reduct J. 8(1):19. doi:10.1186/1477-7517-8-19
   PubMedGoogle Scholar
• Roethig HJ, Zedler BK, Kinser RD, Feng S, Nelson BL, Liang Q. 2007. Short-term clinical exposure evaluation of a second-generation Electrically Heated Cigarette Smoking System. J Clin Pharmacol. 47(4):518–530. doi:10.1177/0091270006297686
   PubMed Web of Science ®Google Scholar
• Royal College of Physicians. 2016. Nicotine without smoke: tobacco harm reduction. A report by the Tobacco Advisory Group of the Royal College of Physicians. London: RCP.
   Google Scholar
• Saareks V, Ylitalo P, Alanko J, Mucha I, Riutta A. 2001. Effects of smoking cessation and nicotine substitution on systemic eicosanoid production in man. Naunyn Schmiedebergs Arch Pharmacol. 363(5):556–561. doi:10.1007/s002100100398
   PubMed Web of Science ®Google Scholar
• Sakaguchi C, Nagata Y, Kikuchi A, Takeshige Y, Minami N. 2021. Differences in levels of biomarkers of potential harm among users of a heat-not-burn tobacco product, cigarette smokers, and never-smokers in Japan: a post-marketing observational study. Nicotine Tob Res. 23(7):1143–1152. doi:10.1093/ntr/ntab014
   PubMed Web of Science ®Google Scholar
• Schaller JP, Keller D, Poget L, Pratte P, Kaelin E, McHugh D, Cudazzo G, Smart D, Tricker AR, Gautier L, et al. 2016. Evaluation of the Tobacco Heating System 2.2. Part 2: chemical composition, genotoxicity, cytotoxicity, and physical properties of the aerosol. Regul Toxicol Pharmacol. 81(Suppl 2):S27–S47. doi:10.1016/j.yrtph.2016.10.001
   PubMedGoogle Scholar
• Schulz KF, Altman DG, Moher D, CONSORT Group. 2010. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med. 8(1):18. doi:10.1186/1741-7015-8-18
   PubMed Web of Science ®Google Scholar
• Scott DA, Stapleton JA, Wilson RF, Sutherland G, Palmer RM, Coward PY, Gustavsson G. 2000. Dramatic decline in circulating intercellular adhesion molecule-1 concentration on quitting tobacco smoking. Blood Cells Mol Dis. 26(3):255–258. doi:10.1006/bcmd.2000.0304
   PubMed Web of Science ®Google Scholar
• Sharman A, Nurmagambetov T. 2020. Changes in respiratory function and physical capacity among smokers after switching to IQOS: one year follow-up. Glob J Respir Care. 6(1):21–27. doi:10.12974/2312-5470.2020.06.03
   Google Scholar
• Simonavicius E, McNeill A, Shahab L, Brose LS. 2018. Heat-not-burn tobacco products: a systematic literature review. Tob Control. 28(5):582–594. doi:10.1136/tobaccocontrol-2018-054419
   PubMed Web of Science ®Google Scholar
• Sinha S, Luben RN, Welch A, Bingham S, Wareham NJ, Day NE, Khaw KT. 2005. Fibrinogen and cigarette smoking in men and women in the European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population. Eur J Cardiovasc Prev Rehabil. 12(2):144–150. doi:10.1097/01.hjr.0000140719.09768.e2
   PubMedGoogle Scholar
• Smith MR, Clark B, Lüdicke F, Schaller J-P, Vanscheeuwijck P, Hoeng J, Peitsch MC. 2016. Evaluation of the Tobacco Heating System 2.2. Part 1: description of the system and the scientific assessment program. Regul Toxicol Pharmacol. 81(Suppl 2):S17–S26. doi:10.1016/j.yrtph.2016.07.006
   PubMedGoogle Scholar
• Spinou A, Birring SS. 2014. An update on measurement and monitoring of cough: what are the important study endpoints? J Thoracic Dis. 6(Suppl 7):S728–S34.
   PubMedGoogle Scholar
• Stephens WE. 2018. Comparing the cancer potencies of emissions from vapourised nicotine products including e-cigarettes with those of tobacco smoke. Tob Control. 27(1):10–17. doi:10.1136/tobaccocontrol-2017-053808
   Web of Science ®Google Scholar
• Stubbe I, Eskilsson J, Nilsson-Ehle P. 1982. High-density lipoprotein concentrations increase after stopping smoking. Br Med J (Clin Res Ed)). 284(6328):1511–1513. doi:10.1136/bmj.284.6328.1511
   PubMedGoogle Scholar
• Sussman RA, Sipala F, Emma R, Ronsisvalle S. 2023. Aerosol emissions from Heated Tobacco Products: a review focusing on carbonyls, methods, and experimental quality. Toxics. 11(12):947. doi:10.3390/toxics11120947
   PubMed Web of Science ®Google Scholar
• Tan XJ, Jiao GP, Ren YJ, Gao XR, Ding Y, Wang XR, Xu H. 2008. Relationship between smoking and dyslipidemia in western Chinese elderly males. J Clin Lab Anal. 22(3):159–163. doi:10.1002/jcla.20235
   PubMed Web of Science ®Google Scholar
• Tonstad S, Urdal P. 2002. Does short-term smoking cessation reduce plasma total homocysteine concentrations? Scand J Clin Lab Invest. 62(4):279–284. doi:10.1080/003655102760145834
   PubMed Web of Science ®Google Scholar
• Tsai JS, Guo FR, Chen SC, Lue BH, Lee LT, Huang KC, Chen CY, Hung SH, Chuang LM, Chen CY. 2012. Changes of serum adiponectin and soluble intercellular adhesion molecule-1 concentrations after smoking cessation. Clin Chem Lab Med. 50(6):1063–1069. doi:10.1515/cclm-2011-0852
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services. 2020. Smoking cessation: a report of the Surgeon General. Smoking cessation: a report of the Surgeon General. Washington (DC): US Department of Health and Human Services.
   Google Scholar
• U.S. Department of Health and Human Services & FDA (Food and Drug Administration). 2012. Docket No. FDA-2012-N-0143]: harmful and potentially harmful constituents in tobacco products and tobacco smoke; established list. Fed Regist. 77(64):20034–20037. [
   Google Scholar
• Velicer WF, Fava JL, Prochaska JO, Abrams DB, Emmons KM, Pierce J. 1995. Distribution of smokers by stage in three representative samples. Prev Med. 24(4):401–411. doi:10.1006/pmed.1995.1065
   PubMed Web of Science ®Google Scholar
• Voulgari C, Katsilambros N, Tentolouris N. 2011. Smoking cessation predicts amelioration of microalbuminuria in newly diagnosed type 2 diabetes mellitus: a 1-year prospective study. Metabolism. 60(10):1456–1464. doi:10.1016/j.metabol.2011.02.014
   PubMed Web of Science ®Google Scholar
• [WHO] World Health Organization. 2003. WHO framework convention on tobacco control.
   Google Scholar
• Willemse BW, ten Hacken NH, Rutgers B, Lesman-Leegte IG, Postma DS, Timens W. 2005. Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers. Eur Respir J. 26(5):835–845. doi:10.1183/09031936.05.00108904
   PubMed Web of Science ®Google Scholar
• Yasue H, Hirai N, Mizuno Y, Harada E, Itoh T, Yoshimura M, Kugiyama K, Ogawa H. 2006. Low-grade inflammation, thrombogenicity, and atherogenic lipid profile in cigarette smokers. Circ J. 70(1):8–13. doi:10.1253/circj.70.8
   PubMed Web of Science ®Google Scholar
• Yuan JM, Koh WP, Murphy SE, Fan Y, Wang R, Carmella SG, Han S, Wickham K, Gao YT, Yu MC, et al. 2009. Urinary levels of tobacco-specific nitrosamine metabolites in relation to lung cancer development in two prospective cohorts of cigarette smokers. Cancer Res. 69(7):2990–2995. doi:10.1158/0008-5472.CAN-08-4330
   PubMed Web of Science ®Google Scholar